Getting your player ready...
The British drug company GlaxoSmithKline said Thursday it agreed to pay $3 billion to settle U.S. government civil and criminal investigations into its sales practices for numerous drugs.
The cases against GlaxoSmithKline include illegal marketing of Avandia, a diabetes drug that was severely restricted last year after it was linked to heart risks. Company whistle-blowers and federal prosecutors said the company had paid doctors and manipulated medical research to promote the drug.
